Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth G Saag

Showing results (251-260 of 374) with videos related to

Pageof 38
Sort By:
Journal of the American Pharmacists Association : Japha|June 13, 2017
Patient-reported reasons for nonadherence to recommended osteoporosis pharmacotherapySylvie F Hall, Stephanie W Edmonds, Yiyue Lou, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|September 21, 2016
Activating Patients With a Tailored Bone Density Test Results Letter and Educational Brochure: the PAADRN Randomized Controlled TrialFredric D Wolinsky, Yiyue Lou, Stephanie W Edmonds, et al.
Patient Education and Counseling|July 7, 2016
Evaluating the effectiveness of a patient storytelling DVD intervention to encourage physician-patient communication about nonsteroidal anti-inflammatory drug (NSAID) useMichael J Miller, Robert Weech-Maldonado, Ryan C Outman, et al.
BMC Musculoskeletal Disorders|March 16, 2017
Sex differences in gout characteristics: tailoring care for women and menLeslie R Harrold, Carol J Etzel, Allan Gibofsky, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 1, 2019
Denosumab Versus Risedronate in Glucocorticoid-Induced Osteoporosis: Final Results of a Twenty-Four-Month Randomized, Double-Blind, Double-Dummy TrialKenneth G Saag, Nicola Pannacciulli, Piet Geusens, et al.
Arthritis and Rheumatism|February 14, 2012
Rates of malignancy associated with juvenile idiopathic arthritis and its treatmentTimothy Beukelman, Kevin Haynes, Jeffrey R Curtis, et al.
Annals of the Rheumatic Diseases|May 19, 2011
The comparative risk of serious infections among rheumatoid arthritis patients starting or switching biological agentsJeffrey R Curtis, Fenglong Xie, Lang Chen, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 23, 2011
Central DXA utilization shifts from office-based to hospital-based settings among medicare beneficiaries in the wake of reimbursement changesJie Zhang, Elizabeth Delzell, Hong Zhao, et al.
Arthritis and Rheumatism|July 30, 2005
Longitudinal patterns in the prevention of osteoporosis in glucocorticoid-treated patientsJeffrey R Curtis, Andrew O Westfall, Jeroan J Allison, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 18, 2021
The Effect of Discontinuing Denosumab in Patients With Rheumatoid Arthritis Treated With GlucocorticoidsKenneth G Saag, Michele T McDermott, Jonathan Adachi, et al.
Pageof 38

Showing results (251-260 of 374) with videos related to

Sort By:
Pageof 38
Journal of the American Pharmacists Association : Japha|June 13, 2017
Patient-reported reasons for nonadherence to recommended osteoporosis pharmacotherapySylvie F Hall, Stephanie W Edmonds, Yiyue Lou, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|September 21, 2016
Activating Patients With a Tailored Bone Density Test Results Letter and Educational Brochure: the PAADRN Randomized Controlled TrialFredric D Wolinsky, Yiyue Lou, Stephanie W Edmonds, et al.
Patient Education and Counseling|July 7, 2016
Evaluating the effectiveness of a patient storytelling DVD intervention to encourage physician-patient communication about nonsteroidal anti-inflammatory drug (NSAID) useMichael J Miller, Robert Weech-Maldonado, Ryan C Outman, et al.
BMC Musculoskeletal Disorders|March 16, 2017
Sex differences in gout characteristics: tailoring care for women and menLeslie R Harrold, Carol J Etzel, Allan Gibofsky, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 1, 2019
Denosumab Versus Risedronate in Glucocorticoid-Induced Osteoporosis: Final Results of a Twenty-Four-Month Randomized, Double-Blind, Double-Dummy TrialKenneth G Saag, Nicola Pannacciulli, Piet Geusens, et al.
Arthritis and Rheumatism|February 14, 2012
Rates of malignancy associated with juvenile idiopathic arthritis and its treatmentTimothy Beukelman, Kevin Haynes, Jeffrey R Curtis, et al.
Annals of the Rheumatic Diseases|May 19, 2011
The comparative risk of serious infections among rheumatoid arthritis patients starting or switching biological agentsJeffrey R Curtis, Fenglong Xie, Lang Chen, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 23, 2011
Central DXA utilization shifts from office-based to hospital-based settings among medicare beneficiaries in the wake of reimbursement changesJie Zhang, Elizabeth Delzell, Hong Zhao, et al.
Arthritis and Rheumatism|July 30, 2005
Longitudinal patterns in the prevention of osteoporosis in glucocorticoid-treated patientsJeffrey R Curtis, Andrew O Westfall, Jeroan J Allison, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 18, 2021
The Effect of Discontinuing Denosumab in Patients With Rheumatoid Arthritis Treated With GlucocorticoidsKenneth G Saag, Michele T McDermott, Jonathan Adachi, et al.
Pageof 38